Pulse Biosciences' Nanosecond Pulsed Field Ablation (nsPFA&#

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology for the treatment of atrial fibrillation, today announced nsPFA will be featured... | May 18, 2023

Related Keywords

United States , Kevin Danahy , Jacobs Koruth , Nasdaq , Pulse Biosciences Inc , Pulse Biosciences , Nanosecond Pulsed Field Ablation , Heart Rhythm , New Orleans , Chief Executive Officer , Deep Ventricular Lesions , Imaging Insights , Preclinical Evaluation , Iwanari Kawamura , Microscopic Insights , Pulsed Field Ablation , Halo Shaped Lesions , Novel Multielectrode System , Initial Preclinical Experience , Nano Pulse Stimulation , Nc Stock Exchange , News , Information , Press Release , Pulse , Company , Eleveraging , Its , Novel , End , Roprietary , Nanosecond , Repulsed , Field , Tablation , Technology , Or , The , Treatment , F , Trial , Oday , Nnounced , Fspfa , Hill , E Plse Us74587b1017 ,